Chronic lymphoproliferative syndromes, including Hodgkin’s and non-Hodgkin’s lymphoma, and chronic and small lymphocytic leukemia (CLL/SLL).

Dr. Thieblemont has made significant contributions to translational research and clinical development in aggressive and indolent B-cell malignancies, bringing extensive experience in overseeing clinical trials across all phases of the development lifecycle. She co-leads the Follicular and Other Indolent Lymphomas committee within the Lymphoma Study Association (LYSA), spearheading research into emerging and novel therapies.

Dr. Thieblemont is the Head of the Hemato-Oncology Department at Hôpital Saint-Louis, Paris, France, and a Professor of Hematology at Paris Cité University.